Cong Deng
Impact in
- Ophthalmology top 5%
- Retinal Diseases and Treatments
- Glaucoma and retinal disorders
- Geriatrics and Gerontology top 10%
- Sirtuins and Resveratrol in Medicine
Papers in
-
- Protein Degradation and Inhibitors 2
- Histone Deacetylase Inhibitors Research 2
-
- Acute Myeloid Leukemia Research 5
- Multiple Myeloma Research and Treatments 3
- Co-authors
- Xu Zhang (3 shared papers)Yulian Pang (3 shared papers)Wei Ye (1 shared paper)Jiejie Zhuang (1 shared paper)Lin Fu (9 shared papers)Jinwei Chen (1 shared paper)Xi Xie (1 shared paper)Tiansheng Zeng (9 shared papers)
- Journals
- The Pharmacogenomics Journal (2 papers)Journal of Cancer Research and Clinical Oncology (2 papers)Journal of Cancer (2 papers)Journal of Psychiatric Research (1 paper)Cancer Biomarkers (1 paper)
- Partner nations
- ChinaNetherlandsItaly
In The Last Decade
Cong Deng
28 papers receiving 336 citations
Peers
Comparison fields: 5 of 80
- Ophthalmology 77
- Geriatrics and Gerontology 30
- Neurology 35
- Molecular Biology 200
- Physiology 11
Countries citing papers authored by Cong Deng
This map shows the geographic impact of Cong Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cong Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cong Deng more than expected).
Fields of papers citing papers by Cong Deng
This network shows the impact of papers produced by Cong Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cong Deng. The network helps show where Cong Deng may publish in the future.
Co-authors
The 25 scholars most cited alongside Cong Deng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 72 | |
| 2 | Autophagy inhibitor regulates apoptosis and proliferation of synovial fibroblasts through the inhibition of PI3K/AKT pathway in collagen-induced arthritis rat model. | 2017 | 48 |
| 3 | 2020 | 33 | |
| 4 | 2016 | 29 | |
| 5 | 2015 | 20 | |
| 6 | 2017 | 19 | |
| 7 | 2015 | 19 | |
| 8 | 2021 | 18 | |
| 9 | 2020 | 14 | |
| 10 | Role of the PGE2 receptor in ischemia-reperfusion injury of the rat retina. | 2020 | 13 |
| 11 | 2023 | 12 | |
| 12 | 2020 | 10 | |
| 13 | 2021 | 6 | |
| 14 | 2021 | 4 | |
| 15 | 2023 | 3 | |
| 16 | 2022 | 3 | |
| 17 | 2023 | 2 | |
| 18 | 2021 | 2 | |
| 19 | 2020 | 2 | |
| 20 | 2021 | 2 |
About Cong Deng
Cong Deng is a scholar working on Molecular Biology, Hematology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Oncology, having authored 30 papers that have together received 341 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (5 papers), Multiple Myeloma Research and Treatments (3 papers), Autophagy in Disease and Therapy (3 papers), Protein Degradation and Inhibitors (2 papers), Glaucoma and retinal disorders (2 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers), Histone Deacetylase Inhibitors Research (2 papers) and Cancer Mechanisms and Therapy (2 papers). The work is most often cited by research in Ophthalmology (77 citations), Geriatrics and Gerontology (30 citations), Neurology (35 citations), Molecular Biology (200 citations) and Physiology (11 citations). Cong Deng has collaborated with scholars based in China, Netherlands and Italy. Frequent co-authors include Xu Zhang, Yulian Pang, Wei Ye, Jiejie Zhuang, Lin Fu, Jinwei Chen, Xi Xie, Tiansheng Zeng, Fen Li and Shu Li. Their work appears in journals such as The Pharmacogenomics Journal, Journal of Cancer Research and Clinical Oncology, Journal of Cancer, Journal of Psychiatric Research and Cancer Biomarkers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.